Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Metro Healthcare Indonesia TbkISX:CARE -1.00%67 Earnings Yield (Joel Greenblatt) % is 0.77% as of Jun. 2026, which is 3750% above its 10-year median of 0.02. GuruFocus rates ISX:CARE with a GF Score™ of 67/100 and a GF Value™ of Rp370.55 (Fairly Valued). The stock has 2 warning signs investors should review. Among 681 Healthcare Providers & Services companies, PT Metro Healthcare Indonesia Tbk ranks worse than 64.9% on this metric.
PT Metro Healthcare Indonesia Tbk's Enterprise Value for the quarter that ended in Jun. 2026 was Rp14,357,703 Mil.
PT Metro Healthcare Indonesia Tbk's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was Rp107,995 Mil. PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 0.77%.
The historical rank and industry rank for PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ISX:CARE'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1.19 Med: 0.02 Max: 0.91
Current: 0.78
During the past 10 years, the highest Earnings Yield (Joel Greenblatt) of PT Metro Healthcare Indonesia Tbk was 0.91%. The lowest was -1.19%. And the median was 0.02%.
ISX:CARE's Earnings Yield (Joel Greenblatt) % is ranked worse than 64.9% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 3.92
vs ISX:CARE: 0.78
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. PT Metro Healthcare Indonesia Tbk's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % falls into.
PT Metro Healthcare Indonesia Tbk Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
PT Metro Healthcare Indonesia Tbk's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp107,995 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 0.77% mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Earnings Yield (Joel Greenblatt) % of 0.77% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. This is 3750% above median its historical median of 0.02. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #442 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 64.9%.
Is PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % too high?
PT Metro Healthcare Indonesia Tbk's current Earnings Yield (Joel Greenblatt) % of 0.77% is 3750% above median its 10-year median of 0.02. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.92. PT Metro Healthcare Indonesia Tbk's value of 0.77% is 80.4% below this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #442 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Earnings Yield (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #442 out of 681 companies for Earnings Yield (Joel Greenblatt) %. This places PT Metro Healthcare Indonesia Tbk in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.92. PT Metro Healthcare Indonesia Tbk's value of 0.77% is 80.4% below this benchmark. While the company's 10-year median is 0.02 vs. the industry median of 3.92, PT Metro Healthcare Indonesia Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.92, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current Earnings Yield (Joel Greenblatt) % of 0.77% is 80.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current Earnings Yield (Joel Greenblatt) % is 0.77%, which is 3750% above median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Fairly Valued. The stock's GF Value™ is Rp370.55, compared to a current price of Rp398.00 — trading 7.4% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 0.77%, which is 3750% above median its 10-year median of 0.02 and 80.4% below the Healthcare Providers & Services industry median of 3.92. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Earnings Yield (Joel Greenblatt) % is 0.77% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp398.00 is trading 7.4% above its estimated GF Value™ of Rp370.55.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Fairly Valued.
Key valuation signals for ISX:CARE:
Earnings Yield (Joel Greenblatt) %: 0.77% (3750% above median its 10-year median of 0.02)
GF Value™: Rp370.55 vs. price of Rp398.00 (7.4% above fair value)
Industry Position: 80.4% below the Healthcare Providers & Services median (#442 of 681)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
67GF Score
Get the complete analysis for ISX:CARE
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
